NCT03854786终止不适用
A Randomized, Placebo-controlled, Multi-blind Study to Assess the Effect of Oxyjun on Aerobic Fitness in Overweight and Obese Individuals.
适应症
试验速览
- 阶段
- 不适用
- 状态
- 终止
- 入组人数
- 11
- 试验地点
- 2
- 主要终点
- To investigate the effect on Oxyjun on aerobic fitness in overweight and obese individuals
研究概览
简要总结
Oxyjun is known for improving cardiovascular endurance. Overweight and obese individuals are at increased risk of cardiovascular complications. To lower the risk, these individuals need to remain physically active with acceptable aerobic fitness.
Hence, the objective of the study is to investigate the effect of Oxyjun on aerobic fitness in physically active overweight and obese individuals. All subjects in the study will be tested for maximum aerobic capacity , body composition, and serum biomarker for fitness.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Other
- 盲法
- Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 35 Years（Adult）
- 性别
- Male
- 接受健康志愿者
- 是
入选标准
- •Body Mass Index ≥ 25 - ≤ 34.9 kg/m
- •Waist Circumference ≥ 80 cms.
- •Non-smoker.
- •BP ≤ 140/90 mm Hg
- •FBS ≤ 125 mg/dl
- •Hb ≥ 11 g/ dl
- •Can abstain from strenuous exercise and alcohol for at least 48 hours.
- •Can abstain from caffeine for at least 24 hours.
排除标准
- •Participants with history of regular (≥2 times a week) structured exercise (gym, walking, yoga, etc).
- •Inter-arm blood pressure is ≥10 mm Hg.
- •Known cases of type II Diabetes Mellitus.
- •Known cases of hypertension with or without anti-hypertensive medication.
- •Visual or balance problems, or who cannot walk on a treadmill without using the handrails.
结局指标
主要结局
To investigate the effect on Oxyjun on aerobic fitness in overweight and obese individuals
时间窗: From baseline to Day 56
Measured by change in VO2 max
次要结局
未报告次要终点
研究者
研究点 (2)
Loading locations...
相似试验
已完成
不适用
A Study to Evaluate the Efficacy of OxyjunTM on Cardiac Pumping Capacity as Well as Work Productivity in Individuals With Metabolic Risk.Metabolic DisorderNCT06496880Vedic Lifesciences Pvt. Ltd.64
已完成
1 期
ALT-801 (Pemvidutide) in Healthy Overweight and Obese Volunteers to Study Safety and TolerabilityObesityNCT04561245Altimmune, Inc.100
撤回
不适用
Blood Cell Response to ExerciseMetabolic SyndromeNCT01872273USDA Grand Forks Human Nutrition Research Center
已完成
不适用
Efficiency of Preoxygenation in Obese Patients: Pressure Assisted Versus Traditional MethodObesityNCT00673634Maisonneuve-Rosemont Hospital30
已完成
不适用
Telerehabilitation in Coronary Heart DiseaseCoronary Artery Disease (CAD) (E.G., Angina, Myocardial Infarction, and Atherosclerotic Heart Disease (ASHD))Percutaneous Transluminal Cutting Balloon Angioplasty of Popliteal Vein Using Fluoroscopic GuidanceMyocardial InfarctionNCT02047942KU Leuven90